StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$29.04+0.21 (+0.73%)

Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –

Supernus operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Supernus's operating cash flow for the twelve months ending Sep 30, 2026 was $96.00M, down 45.8% year over year. For fiscal 2025 it was -$27.00M, down 175.0% from the year before. The highest annual figure on record is $353.00M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.00M-175.0%
FY2024Dec 31, 2024$36.00M–
FY2023Dec 31, 2023-$300.00M–
FY2022Dec 31, 2022-$4.00M-101.1%
FY2021Dec 31, 2021$353.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$97.00M–
Q2 FY2026Jun 30, 2026$229.00M+44.9%
Q1 FY2026Mar 31, 2026-$9.00M-112.0%
Q4 FY2025Dec 31, 2025-$221.00M–
Q3 FY2025Sep 30, 2025-$39.00M-2050.0%
Q2 FY2025Jun 30, 2025$158.00M+79.5%
Q1 FY2025Mar 31, 2025$75.00M–
Q4 FY2024Dec 31, 2024-$17.00M–
Q3 FY2024Sep 30, 2024$2.00M–
Q2 FY2024Jun 30, 2024$88.00M–
Q1 FY2024Mar 31, 2024-$37.00M–

More Supernus figures

See a number that looks wrong?